nodes	percent_of_prediction	percent_of_DWPC	metapath
Framycetin—CXCR4—Binding and entry of HIV virion—PPIA—stomach cancer	0.0857	0.161	CbGpPWpGaD
Framycetin—CXCR4—blood vessel—stomach cancer	0.0636	0.208	CbGeAlD
Framycetin—CXCR4—hematopoietic system—stomach cancer	0.0339	0.111	CbGeAlD
Framycetin—CXCR4—Early Phase of HIV Life Cycle—PPIA—stomach cancer	0.0314	0.0592	CbGpPWpGaD
Framycetin—CXCR4—epithelium—stomach cancer	0.031	0.101	CbGeAlD
Framycetin—CXCR4—smooth muscle tissue—stomach cancer	0.0298	0.0977	CbGeAlD
Framycetin—CXCR4—pancreas—stomach cancer	0.0276	0.0903	CbGeAlD
Framycetin—CXCR4—lymphoid tissue—stomach cancer	0.0238	0.0781	CbGeAlD
Framycetin—CXCR4—digestive system—stomach cancer	0.0236	0.0771	CbGeAlD
Framycetin—CXCR4—Syndecan-4-mediated signaling events—ITGA5—stomach cancer	0.0227	0.0428	CbGpPWpGaD
Framycetin—CXCR4—bone marrow—stomach cancer	0.0217	0.0711	CbGeAlD
Framycetin—CXCR4—endocrine gland—stomach cancer	0.0195	0.0637	CbGeAlD
Framycetin—CXCR4—Cardiac Progenitor Differentiation—ACTC1—stomach cancer	0.0193	0.0364	CbGpPWpGaD
Framycetin—CXCR4—HIF-1-alpha transcription factor network—BNIP3—stomach cancer	0.0182	0.0343	CbGpPWpGaD
Framycetin—CXCR4—liver—stomach cancer	0.0175	0.0575	CbGeAlD
Framycetin—Nephropathy toxic—Mitomycin—stomach cancer	0.0167	0.102	CcSEcCtD
Framycetin—CXCR4—HIF-1-alpha transcription factor network—PLIN2—stomach cancer	0.0153	0.0287	CbGpPWpGaD
Framycetin—CXCR4—HIF-1-alpha transcription factor network—NT5E—stomach cancer	0.0145	0.0272	CbGpPWpGaD
Framycetin—Ototoxicity—Docetaxel—stomach cancer	0.0143	0.0875	CcSEcCtD
Framycetin—Malabsorption—Methotrexate—stomach cancer	0.0143	0.0872	CcSEcCtD
Framycetin—CXCR4—lymph node—stomach cancer	0.0135	0.044	CbGeAlD
Framycetin—CXCR4—HIF-1-alpha transcription factor network—RORA—stomach cancer	0.0107	0.0202	CbGpPWpGaD
Framycetin—CXCR4—HIF-1-alpha transcription factor network—NPM1—stomach cancer	0.00965	0.0182	CbGpPWpGaD
Framycetin—CXCR4—Cardiac Progenitor Differentiation—PAX6—stomach cancer	0.00919	0.0173	CbGpPWpGaD
Framycetin—CXCR4—Peptide ligand-binding receptors—KISS1R—stomach cancer	0.00819	0.0154	CbGpPWpGaD
Framycetin—CXCR4—HIF-1-alpha transcription factor network—ENO1—stomach cancer	0.0076	0.0143	CbGpPWpGaD
Framycetin—CXCR4—Peptide GPCRs—AGTR2—stomach cancer	0.00731	0.0138	CbGpPWpGaD
Framycetin—CXCR4—S1P3 pathway—RHOA—stomach cancer	0.00699	0.0132	CbGpPWpGaD
Framycetin—Secondary infection—Epirubicin—stomach cancer	0.0066	0.0403	CcSEcCtD
Framycetin—Secondary infection—Doxorubicin—stomach cancer	0.0061	0.0373	CcSEcCtD
Framycetin—CXCR4—Syndecan-4-mediated signaling events—RHOA—stomach cancer	0.00574	0.0108	CbGpPWpGaD
Framycetin—CXCR4—HIF-1-alpha transcription factor network—HMOX1—stomach cancer	0.00554	0.0104	CbGpPWpGaD
Framycetin—CXCR4—Class A/1 (Rhodopsin-like receptors)—KISS1R—stomach cancer	0.00549	0.0103	CbGpPWpGaD
Framycetin—Sensitisation—Epirubicin—stomach cancer	0.00543	0.0332	CcSEcCtD
Framycetin—Erythema—Floxuridine—stomach cancer	0.00533	0.0326	CcSEcCtD
Framycetin—CXCR4—HIF-1-alpha transcription factor network—SMAD4—stomach cancer	0.00532	0.01	CbGpPWpGaD
Framycetin—CXCR4—Peptide ligand-binding receptors—KISS1—stomach cancer	0.00528	0.00994	CbGpPWpGaD
Framycetin—CXCR4—HIV Life Cycle—PPIA—stomach cancer	0.0051	0.00961	CbGpPWpGaD
Framycetin—Sensitisation—Doxorubicin—stomach cancer	0.00502	0.0307	CcSEcCtD
Framycetin—CXCR4—G alpha (i) signalling events—HRH4—stomach cancer	0.005	0.00941	CbGpPWpGaD
Framycetin—CXCR4—S1P3 pathway—VEGFA—stomach cancer	0.00499	0.00939	CbGpPWpGaD
Framycetin—Impaired healing—Methotrexate—stomach cancer	0.00479	0.0293	CcSEcCtD
Framycetin—CXCR4—S1P3 pathway—MAPK3—stomach cancer	0.00472	0.00888	CbGpPWpGaD
Framycetin—CXCR4—Syndecan-4-mediated signaling events—MMP9—stomach cancer	0.00456	0.00858	CbGpPWpGaD
Framycetin—CXCR4—S1P3 pathway—MAPK1—stomach cancer	0.00449	0.00845	CbGpPWpGaD
Framycetin—Anaphylactic shock—Floxuridine—stomach cancer	0.00435	0.0266	CcSEcCtD
Framycetin—Infection—Floxuridine—stomach cancer	0.00432	0.0264	CcSEcCtD
Framycetin—Erythema—Mitomycin—stomach cancer	0.00419	0.0256	CcSEcCtD
Framycetin—CXCR4—GPCR ligand binding—KISS1R—stomach cancer	0.00418	0.00788	CbGpPWpGaD
Framycetin—CXCR4—CXCR4-mediated signaling events—FYN—stomach cancer	0.00416	0.00784	CbGpPWpGaD
Framycetin—CXCR4—Hematopoietic Stem Cell Differentiation—IL1B—stomach cancer	0.00404	0.00762	CbGpPWpGaD
Framycetin—CXCR4—Class A/1 (Rhodopsin-like receptors)—HRH4—stomach cancer	0.00397	0.00748	CbGpPWpGaD
Framycetin—CXCR4—HIV Infection—NPM1—stomach cancer	0.00374	0.00704	CbGpPWpGaD
Framycetin—CXCR4—Class A/1 (Rhodopsin-like receptors)—KISS1—stomach cancer	0.00354	0.00667	CbGpPWpGaD
Framycetin—CXCR4—HIV Infection—PPIA—stomach cancer	0.00352	0.00664	CbGpPWpGaD
Framycetin—CXCR4—Peptide ligand-binding receptors—AGTR2—stomach cancer	0.00344	0.00648	CbGpPWpGaD
Framycetin—CXCR4—Peptide ligand-binding receptors—F2R—stomach cancer	0.0034	0.00641	CbGpPWpGaD
Framycetin—CXCR4—HIF-1-alpha transcription factor network—SERPINE1—stomach cancer	0.00333	0.00628	CbGpPWpGaD
Framycetin—Swelling—Fluorouracil—stomach cancer	0.00328	0.02	CcSEcCtD
Framycetin—CXCR4—Chemokine receptors bind chemokines—CXCL8—stomach cancer	0.00322	0.00607	CbGpPWpGaD
Framycetin—Hypersensitivity—Floxuridine—stomach cancer	0.00321	0.0196	CcSEcCtD
Framycetin—CXCR4—Peptide ligand-binding receptors—ANXA1—stomach cancer	0.0032	0.00602	CbGpPWpGaD
Framycetin—CXCR4—GPCR ligand binding—HRH4—stomach cancer	0.00302	0.0057	CbGpPWpGaD
Framycetin—Diarrhoea—Floxuridine—stomach cancer	0.00298	0.0182	CcSEcCtD
Framycetin—CXCR4—G alpha (i) signalling events—AGTR2—stomach cancer	0.0029	0.00547	CbGpPWpGaD
Framycetin—CXCR4—G alpha (i) signalling events—HTR1A—stomach cancer	0.00279	0.00526	CbGpPWpGaD
Framycetin—Vomiting—Floxuridine—stomach cancer	0.00277	0.0169	CcSEcCtD
Framycetin—CXCR4—HIV Life Cycle—ERCC2—stomach cancer	0.00272	0.00513	CbGpPWpGaD
Framycetin—CXCR4—G alpha (i) signalling events—ANXA1—stomach cancer	0.0027	0.00508	CbGpPWpGaD
Framycetin—CXCR4—GPCR ligand binding—KISS1—stomach cancer	0.0027	0.00508	CbGpPWpGaD
Framycetin—CXCR4—GPCRs, Class A Rhodopsin-like—AGTR2—stomach cancer	0.00269	0.00507	CbGpPWpGaD
Framycetin—CXCR4—GPCRs, Class A Rhodopsin-like—F2R—stomach cancer	0.00266	0.00502	CbGpPWpGaD
Framycetin—CXCR4—CXCR4-mediated signaling events—RHOA—stomach cancer	0.00265	0.005	CbGpPWpGaD
Framycetin—CXCR4—HIF-1-alpha transcription factor network—JUN—stomach cancer	0.00263	0.00494	CbGpPWpGaD
Framycetin—CXCR4—GPCRs, Class A Rhodopsin-like—HTR1A—stomach cancer	0.00259	0.00488	CbGpPWpGaD
Framycetin—Nausea—Floxuridine—stomach cancer	0.00259	0.0158	CcSEcCtD
Framycetin—CXCR4—GPCRs, Class A Rhodopsin-like—ADRB1—stomach cancer	0.00242	0.00457	CbGpPWpGaD
Framycetin—CXCR4—Hematopoietic Stem Cell Differentiation—IL6—stomach cancer	0.00237	0.00446	CbGpPWpGaD
Framycetin—Swelling—Docetaxel—stomach cancer	0.00237	0.0144	CcSEcCtD
Framycetin—CXCR4—GPCR downstream signaling—KISS1R—stomach cancer	0.00236	0.00445	CbGpPWpGaD
Framycetin—Diarrhoea—Mitomycin—stomach cancer	0.00234	0.0143	CcSEcCtD
Framycetin—CXCR4—Class A/1 (Rhodopsin-like receptors)—AGTR2—stomach cancer	0.00231	0.00435	CbGpPWpGaD
Framycetin—CXCR4—HIF-1-alpha transcription factor network—VEGFA—stomach cancer	0.00229	0.00432	CbGpPWpGaD
Framycetin—Swelling—Capecitabine—stomach cancer	0.00229	0.014	CcSEcCtD
Framycetin—CXCR4—Class A/1 (Rhodopsin-like receptors)—F2R—stomach cancer	0.00228	0.0043	CbGpPWpGaD
Framycetin—CXCR4—Class A/1 (Rhodopsin-like receptors)—HTR1A—stomach cancer	0.00222	0.00418	CbGpPWpGaD
Framycetin—Vomiting—Mitomycin—stomach cancer	0.00217	0.0133	CcSEcCtD
Framycetin—CXCR4—Signaling by GPCR—KISS1R—stomach cancer	0.00215	0.00404	CbGpPWpGaD
Framycetin—Viral infection—Epirubicin—stomach cancer	0.00215	0.0131	CcSEcCtD
Framycetin—CXCR4—Class A/1 (Rhodopsin-like receptors)—ANXA1—stomach cancer	0.00214	0.00404	CbGpPWpGaD
Framycetin—CXCR4—CXCR4-mediated signaling events—MMP9—stomach cancer	0.00211	0.00397	CbGpPWpGaD
Framycetin—CXCR4—Class A/1 (Rhodopsin-like receptors)—ADRB1—stomach cancer	0.00208	0.00391	CbGpPWpGaD
Framycetin—Nausea—Mitomycin—stomach cancer	0.00203	0.0124	CcSEcCtD
Framycetin—Viral infection—Doxorubicin—stomach cancer	0.00199	0.0121	CcSEcCtD
Framycetin—CXCR4—GPCRs, Class A Rhodopsin-like—ADRB2—stomach cancer	0.00196	0.0037	CbGpPWpGaD
Framycetin—CXCR4—HIV Infection—FYN—stomach cancer	0.00196	0.00369	CbGpPWpGaD
Framycetin—CXCR4—HIV Infection—ERCC2—stomach cancer	0.00188	0.00354	CbGpPWpGaD
Framycetin—CXCR4—CXCR4-mediated signaling events—STAT3—stomach cancer	0.00187	0.00353	CbGpPWpGaD
Framycetin—CXCR4—Disease—PGLS—stomach cancer	0.00181	0.00341	CbGpPWpGaD
Framycetin—CXCR4—GPCR ligand binding—AGTR2—stomach cancer	0.00176	0.00331	CbGpPWpGaD
Framycetin—Erythema—Fluorouracil—stomach cancer	0.00174	0.0106	CcSEcCtD
Framycetin—CXCR4—GPCR ligand binding—F2R—stomach cancer	0.00174	0.00327	CbGpPWpGaD
Framycetin—CXCR4—Disease—RBP1—stomach cancer	0.00173	0.00325	CbGpPWpGaD
Framycetin—CXCR4—GPCR downstream signaling—HRH4—stomach cancer	0.00171	0.00322	CbGpPWpGaD
Framycetin—CXCR4—GPCR ligand binding—HTR1A—stomach cancer	0.00169	0.00319	CbGpPWpGaD
Framycetin—CXCR4—Class A/1 (Rhodopsin-like receptors)—ADRB2—stomach cancer	0.00168	0.00317	CbGpPWpGaD
Framycetin—CXCR4—GPCR ligand binding—ANXA1—stomach cancer	0.00163	0.00308	CbGpPWpGaD
Framycetin—CXCR4—GPCR ligand binding—ADRB1—stomach cancer	0.00158	0.00298	CbGpPWpGaD
Framycetin—CXCR4—Signaling by GPCR—HRH4—stomach cancer	0.00155	0.00292	CbGpPWpGaD
Framycetin—CXCR4—Disease—FBP1—stomach cancer	0.00154	0.0029	CbGpPWpGaD
Framycetin—CXCR4—GPCR downstream signaling—KISS1—stomach cancer	0.00152	0.00287	CbGpPWpGaD
Framycetin—Anaphylactic shock—Irinotecan—stomach cancer	0.00148	0.00906	CcSEcCtD
Framycetin—CXCR4—CXCR4-mediated signaling events—PIK3CA—stomach cancer	0.00148	0.00278	CbGpPWpGaD
Framycetin—Infection—Irinotecan—stomach cancer	0.00147	0.009	CcSEcCtD
Framycetin—Anaphylactic shock—Fluorouracil—stomach cancer	0.00142	0.00868	CcSEcCtD
Framycetin—Infection—Fluorouracil—stomach cancer	0.00141	0.00862	CcSEcCtD
Framycetin—CXCR4—Signaling by GPCR—KISS1—stomach cancer	0.00138	0.00261	CbGpPWpGaD
Framycetin—CXCR4—Disease—PGAM1—stomach cancer	0.00137	0.00259	CbGpPWpGaD
Framycetin—CXCR4—GPCR downstream signaling—RGS2—stomach cancer	0.00131	0.00247	CbGpPWpGaD
Framycetin—CXCR4—GPCR downstream signaling—GAST—stomach cancer	0.00131	0.00247	CbGpPWpGaD
Framycetin—CXCR4—Disease—WIF1—stomach cancer	0.00131	0.00247	CbGpPWpGaD
Framycetin—CXCR4—GPCR ligand binding—ADRB2—stomach cancer	0.00128	0.00241	CbGpPWpGaD
Framycetin—CXCR4—Signaling Pathways—GLI3—stomach cancer	0.00127	0.00239	CbGpPWpGaD
Framycetin—CXCR4—Signaling Pathways—KISS1R—stomach cancer	0.00127	0.00239	CbGpPWpGaD
Framycetin—Erythema—Docetaxel—stomach cancer	0.00126	0.00768	CcSEcCtD
Framycetin—CXCR4—Disease—RPL13—stomach cancer	0.00123	0.00232	CbGpPWpGaD
Framycetin—CXCR4—Disease—RPL18—stomach cancer	0.00123	0.00232	CbGpPWpGaD
Framycetin—Erythema—Capecitabine—stomach cancer	0.00122	0.00743	CcSEcCtD
Framycetin—CXCR4—Peptide ligand-binding receptors—CXCL8—stomach cancer	0.00121	0.00228	CbGpPWpGaD
Framycetin—CXCR4—Signaling Pathways—RBP1—stomach cancer	0.00121	0.00228	CbGpPWpGaD
Framycetin—CXCR4—Signaling by GPCR—RGS2—stomach cancer	0.00119	0.00224	CbGpPWpGaD
Framycetin—CXCR4—Signaling by GPCR—GAST—stomach cancer	0.00119	0.00224	CbGpPWpGaD
Framycetin—CXCR4—Disease—RNF43—stomach cancer	0.00117	0.0022	CbGpPWpGaD
Framycetin—CXCR4—Disease—RPS21—stomach cancer	0.00115	0.00216	CbGpPWpGaD
Framycetin—CXCR4—Disease—RPS15—stomach cancer	0.00115	0.00216	CbGpPWpGaD
Framycetin—Hypersensitivity—Irinotecan—stomach cancer	0.00109	0.00668	CcSEcCtD
Framycetin—Hypersensitivity—Fluorouracil—stomach cancer	0.00105	0.0064	CcSEcCtD
Framycetin—Anaphylactic shock—Docetaxel—stomach cancer	0.00103	0.00626	CcSEcCtD
Framycetin—CXCR4—G alpha (i) signalling events—CXCL8—stomach cancer	0.00102	0.00193	CbGpPWpGaD
Framycetin—Infection—Docetaxel—stomach cancer	0.00102	0.00622	CcSEcCtD
Framycetin—Diarrhoea—Irinotecan—stomach cancer	0.00102	0.0062	CcSEcCtD
Framycetin—Pruritus—Fluorouracil—stomach cancer	0.00101	0.00614	CcSEcCtD
Framycetin—CXCR4—GPCR downstream signaling—AGTR2—stomach cancer	0.000993	0.00187	CbGpPWpGaD
Framycetin—Infection—Capecitabine—stomach cancer	0.000986	0.00603	CcSEcCtD
Framycetin—CXCR4—Signaling Pathways—WWOX—stomach cancer	0.000986	0.00186	CbGpPWpGaD
Framycetin—CXCR4—GPCR downstream signaling—F2R—stomach cancer	0.000982	0.00185	CbGpPWpGaD
Framycetin—Diarrhoea—Fluorouracil—stomach cancer	0.000972	0.00594	CcSEcCtD
Framycetin—CXCR4—GPCR downstream signaling—HTR1A—stomach cancer	0.000956	0.0018	CbGpPWpGaD
Framycetin—CXCR4—Disease—ALDOB—stomach cancer	0.000951	0.00179	CbGpPWpGaD
Framycetin—Vomiting—Irinotecan—stomach cancer	0.000943	0.00576	CcSEcCtD
Framycetin—CXCR4—Disease—RPL15—stomach cancer	0.000933	0.00176	CbGpPWpGaD
Framycetin—CXCR4—GPCR downstream signaling—ANXA1—stomach cancer	0.000923	0.00174	CbGpPWpGaD
Framycetin—CXCR4—Signaling Pathways—HRH4—stomach cancer	0.000917	0.00173	CbGpPWpGaD
Framycetin—CXCR4—Signaling Pathways—WIF1—stomach cancer	0.000917	0.00173	CbGpPWpGaD
Framycetin—CXCR4—Disease—NPM1—stomach cancer	0.000916	0.00173	CbGpPWpGaD
Framycetin—Erythema—Methotrexate—stomach cancer	0.000906	0.00553	CcSEcCtD
Framycetin—Vomiting—Fluorouracil—stomach cancer	0.000903	0.00552	CcSEcCtD
Framycetin—CXCR4—Signaling by GPCR—AGTR2—stomach cancer	0.000902	0.0017	CbGpPWpGaD
Framycetin—CXCR4—GPCR downstream signaling—ADRB1—stomach cancer	0.000894	0.00168	CbGpPWpGaD
Framycetin—CXCR4—Signaling by GPCR—F2R—stomach cancer	0.000892	0.00168	CbGpPWpGaD
Framycetin—CXCR4—Disease—RBP4—stomach cancer	0.000884	0.00167	CbGpPWpGaD
Framycetin—Nausea—Irinotecan—stomach cancer	0.000881	0.00538	CcSEcCtD
Framycetin—CXCR4—Disease—RPS26—stomach cancer	0.00087	0.00164	CbGpPWpGaD
Framycetin—CXCR4—Signaling by GPCR—HTR1A—stomach cancer	0.000868	0.00163	CbGpPWpGaD
Framycetin—CXCR4—Disease—PPIA—stomach cancer	0.000863	0.00163	CbGpPWpGaD
Framycetin—Erythema—Epirubicin—stomach cancer	0.000848	0.00518	CcSEcCtD
Framycetin—CXCR4—Signaling Pathways—PRKAB1—stomach cancer	0.000846	0.00159	CbGpPWpGaD
Framycetin—Nausea—Fluorouracil—stomach cancer	0.000844	0.00516	CcSEcCtD
Framycetin—CXCR4—Signaling by GPCR—ANXA1—stomach cancer	0.000838	0.00158	CbGpPWpGaD
Framycetin—CXCR4—Signaling Pathways—RNF43—stomach cancer	0.000817	0.00154	CbGpPWpGaD
Framycetin—CXCR4—Signaling Pathways—KISS1—stomach cancer	0.000817	0.00154	CbGpPWpGaD
Framycetin—CXCR4—Class A/1 (Rhodopsin-like receptors)—CXCL8—stomach cancer	0.000813	0.00153	CbGpPWpGaD
Framycetin—CXCR4—Signaling by GPCR—ADRB1—stomach cancer	0.000812	0.00153	CbGpPWpGaD
Framycetin—Erythema—Doxorubicin—stomach cancer	0.000784	0.00479	CcSEcCtD
Framycetin—Hypersensitivity—Docetaxel—stomach cancer	0.000756	0.00462	CcSEcCtD
Framycetin—CXCR4—Disease—RPS19—stomach cancer	0.00074	0.00139	CbGpPWpGaD
Framycetin—CXCR4—Disease—AKR1C3—stomach cancer	0.00074	0.00139	CbGpPWpGaD
Framycetin—Anaphylactic shock—Methotrexate—stomach cancer	0.000739	0.00452	CcSEcCtD
Framycetin—Infection—Methotrexate—stomach cancer	0.000734	0.00449	CcSEcCtD
Framycetin—Hypersensitivity—Capecitabine—stomach cancer	0.000732	0.00447	CcSEcCtD
Framycetin—CXCR4—Signaling Pathways—FST—stomach cancer	0.000728	0.00137	CbGpPWpGaD
Framycetin—Pruritus—Docetaxel—stomach cancer	0.000726	0.00443	CcSEcCtD
Framycetin—CXCR4—GPCR downstream signaling—ADRB2—stomach cancer	0.000724	0.00136	CbGpPWpGaD
Framycetin—CXCR4—Disease—ENO1—stomach cancer	0.000721	0.00136	CbGpPWpGaD
Framycetin—CXCR4—Signaling by GPCR—HBEGF—stomach cancer	0.000713	0.00134	CbGpPWpGaD
Framycetin—CXCR4—Signaling Pathways—GAST—stomach cancer	0.000703	0.00132	CbGpPWpGaD
Framycetin—CXCR4—Signaling Pathways—RGS2—stomach cancer	0.000703	0.00132	CbGpPWpGaD
Framycetin—Pruritus—Capecitabine—stomach cancer	0.000702	0.00429	CcSEcCtD
Framycetin—Diarrhoea—Docetaxel—stomach cancer	0.000702	0.00429	CcSEcCtD
Framycetin—Anaphylactic shock—Epirubicin—stomach cancer	0.000692	0.00423	CcSEcCtD
Framycetin—Infection—Epirubicin—stomach cancer	0.000687	0.0042	CcSEcCtD
Framycetin—Diarrhoea—Capecitabine—stomach cancer	0.000679	0.00415	CcSEcCtD
Framycetin—CXCR4—Signaling Pathways—FGG—stomach cancer	0.000666	0.00125	CbGpPWpGaD
Framycetin—CXCR4—Signaling by GPCR—ADRB2—stomach cancer	0.000658	0.00124	CbGpPWpGaD
Framycetin—CXCR4—Disease—RPS6—stomach cancer	0.000654	0.00123	CbGpPWpGaD
Framycetin—Vomiting—Docetaxel—stomach cancer	0.000652	0.00398	CcSEcCtD
Framycetin—CXCR4—Signaling by GPCR—PPP2R1A—stomach cancer	0.000645	0.00121	CbGpPWpGaD
Framycetin—CXCR4—Signaling Pathways—PRKAA1—stomach cancer	0.000641	0.00121	CbGpPWpGaD
Framycetin—Anaphylactic shock—Doxorubicin—stomach cancer	0.00064	0.00391	CcSEcCtD
Framycetin—CXCR4—Disease—CD44—stomach cancer	0.000639	0.0012	CbGpPWpGaD
Framycetin—Infection—Doxorubicin—stomach cancer	0.000636	0.00388	CcSEcCtD
Framycetin—Vomiting—Capecitabine—stomach cancer	0.000631	0.00386	CcSEcCtD
Framycetin—CXCR4—Signaling Pathways—RBP4—stomach cancer	0.000619	0.00117	CbGpPWpGaD
Framycetin—CXCR4—GPCR ligand binding—CXCL8—stomach cancer	0.000619	0.00117	CbGpPWpGaD
Framycetin—Nausea—Docetaxel—stomach cancer	0.000609	0.00372	CcSEcCtD
Framycetin—CXCR4—Disease—HBEGF—stomach cancer	0.000601	0.00113	CbGpPWpGaD
Framycetin—Nausea—Capecitabine—stomach cancer	0.00059	0.0036	CcSEcCtD
Framycetin—Hypersensitivity—Methotrexate—stomach cancer	0.000545	0.00333	CcSEcCtD
Framycetin—CXCR4—Disease—PPP2R1A—stomach cancer	0.000544	0.00102	CbGpPWpGaD
Framycetin—CXCR4—Signaling Pathways—AGTR2—stomach cancer	0.000533	0.001	CbGpPWpGaD
Framycetin—CXCR4—Signaling Pathways—HSPB1—stomach cancer	0.000533	0.001	CbGpPWpGaD
Framycetin—CXCR4—Signaling Pathways—BMP2—stomach cancer	0.000527	0.000992	CbGpPWpGaD
Framycetin—CXCR4—Signaling Pathways—F2R—stomach cancer	0.000527	0.000992	CbGpPWpGaD
Framycetin—Pruritus—Methotrexate—stomach cancer	0.000523	0.00319	CcSEcCtD
Framycetin—CXCR4—Signaling Pathways—AKR1C3—stomach cancer	0.000518	0.000976	CbGpPWpGaD
Framycetin—CXCR4—Signaling Pathways—HTR1A—stomach cancer	0.000513	0.000966	CbGpPWpGaD
Framycetin—Hypersensitivity—Epirubicin—stomach cancer	0.00051	0.00311	CcSEcCtD
Framycetin—Diarrhoea—Methotrexate—stomach cancer	0.000506	0.00309	CcSEcCtD
Framycetin—CXCR4—Disease—SMAD4—stomach cancer	0.000505	0.000951	CbGpPWpGaD
Framycetin—CXCR4—GPCR downstream signaling—PRKCB—stomach cancer	0.000496	0.000935	CbGpPWpGaD
Framycetin—CXCR4—Signaling Pathways—ANXA1—stomach cancer	0.000495	0.000933	CbGpPWpGaD
Framycetin—Pruritus—Epirubicin—stomach cancer	0.000489	0.00299	CcSEcCtD
Framycetin—CXCR4—Signaling Pathways—ADRB1—stomach cancer	0.00048	0.000903	CbGpPWpGaD
Framycetin—CXCR4—Disease—FYN—stomach cancer	0.000479	0.000903	CbGpPWpGaD
Framycetin—Diarrhoea—Epirubicin—stomach cancer	0.000473	0.00289	CcSEcCtD
Framycetin—Hypersensitivity—Doxorubicin—stomach cancer	0.000472	0.00288	CcSEcCtD
Framycetin—Vomiting—Methotrexate—stomach cancer	0.00047	0.00287	CcSEcCtD
Framycetin—CXCR4—Disease—ERCC2—stomach cancer	0.000461	0.000868	CbGpPWpGaD
Framycetin—CXCR4—Signaling Pathways—RPS6—stomach cancer	0.000458	0.000863	CbGpPWpGaD
Framycetin—Pruritus—Doxorubicin—stomach cancer	0.000453	0.00277	CcSEcCtD
Framycetin—CXCR4—Signaling by GPCR—PRKCB—stomach cancer	0.000451	0.000849	CbGpPWpGaD
Framycetin—CXCR4—Disease—FGFR2—stomach cancer	0.00045	0.000848	CbGpPWpGaD
Framycetin—CXCR4—Signaling by GPCR—IL6ST—stomach cancer	0.000449	0.000846	CbGpPWpGaD
Framycetin—Vomiting—Epirubicin—stomach cancer	0.00044	0.00269	CcSEcCtD
Framycetin—Nausea—Methotrexate—stomach cancer	0.000439	0.00268	CcSEcCtD
Framycetin—Diarrhoea—Doxorubicin—stomach cancer	0.000438	0.00268	CcSEcCtD
Framycetin—CXCR4—Disease—MTHFR—stomach cancer	0.000433	0.000816	CbGpPWpGaD
Framycetin—CXCR4—Signaling Pathways—HBEGF—stomach cancer	0.000421	0.000793	CbGpPWpGaD
Framycetin—CXCR4—Disease—IRS2—stomach cancer	0.000412	0.000776	CbGpPWpGaD
Framycetin—Nausea—Epirubicin—stomach cancer	0.000411	0.00251	CcSEcCtD
Framycetin—Vomiting—Doxorubicin—stomach cancer	0.000407	0.00249	CcSEcCtD
Framycetin—CXCR4—Signaling by GPCR—IL6R—stomach cancer	0.000401	0.000755	CbGpPWpGaD
Framycetin—CXCR4—Disease—CAV1—stomach cancer	0.0004	0.000753	CbGpPWpGaD
Framycetin—CXCR4—Disease—APOA1—stomach cancer	0.000399	0.000751	CbGpPWpGaD
Framycetin—CXCR4—GPCR downstream signaling—RHOA—stomach cancer	0.000398	0.000751	CbGpPWpGaD
Framycetin—CXCR4—Signaling Pathways—ADRB2—stomach cancer	0.000389	0.000732	CbGpPWpGaD
Framycetin—CXCR4—Signaling Pathways—PPP2R1A—stomach cancer	0.000381	0.000717	CbGpPWpGaD
Framycetin—Nausea—Doxorubicin—stomach cancer	0.00038	0.00232	CcSEcCtD
Framycetin—CXCR4—Disease—IL6ST—stomach cancer	0.000379	0.000713	CbGpPWpGaD
Framycetin—CXCR4—Disease—APC—stomach cancer	0.000364	0.000686	CbGpPWpGaD
Framycetin—CXCR4—Signaling by GPCR—RHOA—stomach cancer	0.000362	0.000682	CbGpPWpGaD
Framycetin—CXCR4—Signaling Pathways—SMAD4—stomach cancer	0.000354	0.000666	CbGpPWpGaD
Framycetin—CXCR4—GPCR downstream signaling—CXCL8—stomach cancer	0.00035	0.000659	CbGpPWpGaD
Framycetin—CXCR4—Disease—IL6R—stomach cancer	0.000338	0.000637	CbGpPWpGaD
Framycetin—CXCR4—Signaling Pathways—FYN—stomach cancer	0.000336	0.000632	CbGpPWpGaD
Framycetin—CXCR4—Signaling by GPCR—CXCL8—stomach cancer	0.000318	0.000598	CbGpPWpGaD
Framycetin—CXCR4—Disease—SERPINE1—stomach cancer	0.000316	0.000596	CbGpPWpGaD
Framycetin—CXCR4—Signaling Pathways—FGFR2—stomach cancer	0.000315	0.000594	CbGpPWpGaD
Framycetin—CXCR4—Disease—RHOA—stomach cancer	0.000305	0.000575	CbGpPWpGaD
Framycetin—CXCR4—Disease—NOS3—stomach cancer	0.000302	0.000569	CbGpPWpGaD
Framycetin—CXCR4—Signaling Pathways—IRS2—stomach cancer	0.000289	0.000544	CbGpPWpGaD
Framycetin—CXCR4—Disease—ERBB2—stomach cancer	0.000283	0.000532	CbGpPWpGaD
Framycetin—CXCR4—Signaling Pathways—CAV1—stomach cancer	0.00028	0.000527	CbGpPWpGaD
Framycetin—CXCR4—Signaling Pathways—APOA1—stomach cancer	0.000279	0.000526	CbGpPWpGaD
Framycetin—CXCR4—Disease—PTGS2—stomach cancer	0.000276	0.00052	CbGpPWpGaD
Framycetin—CXCR4—Signaling Pathways—PRKCB—stomach cancer	0.000266	0.000502	CbGpPWpGaD
Framycetin—CXCR4—Signaling Pathways—IL6ST—stomach cancer	0.000265	0.0005	CbGpPWpGaD
Framycetin—CXCR4—Disease—CDKN1B—stomach cancer	0.000262	0.000493	CbGpPWpGaD
Framycetin—CXCR4—Signaling Pathways—APC—stomach cancer	0.000255	0.00048	CbGpPWpGaD
Framycetin—CXCR4—Signaling by GPCR—MAPK3—stomach cancer	0.000244	0.00046	CbGpPWpGaD
Framycetin—CXCR4—Disease—CDKN1A—stomach cancer	0.000242	0.000455	CbGpPWpGaD
Framycetin—CXCR4—Signaling Pathways—IL6R—stomach cancer	0.000237	0.000446	CbGpPWpGaD
Framycetin—CXCR4—Signaling by GPCR—MAPK1—stomach cancer	0.000232	0.000437	CbGpPWpGaD
Framycetin—CXCR4—Signaling by GPCR—EGFR—stomach cancer	0.000232	0.000437	CbGpPWpGaD
Framycetin—CXCR4—GPCR downstream signaling—PIK3CA—stomach cancer	0.000222	0.000418	CbGpPWpGaD
Framycetin—CXCR4—Signaling Pathways—SERPINE1—stomach cancer	0.000222	0.000417	CbGpPWpGaD
Framycetin—CXCR4—Signaling by GPCR—KRAS—stomach cancer	0.000219	0.000413	CbGpPWpGaD
Framycetin—CXCR4—Disease—STAT3—stomach cancer	0.000216	0.000406	CbGpPWpGaD
Framycetin—CXCR4—Signaling Pathways—RHOA—stomach cancer	0.000214	0.000403	CbGpPWpGaD
Framycetin—CXCR4—Signaling Pathways—NOS3—stomach cancer	0.000212	0.000398	CbGpPWpGaD
Framycetin—CXCR4—Disease—MAPK3—stomach cancer	0.000206	0.000388	CbGpPWpGaD
Framycetin—CXCR4—Signaling by GPCR—PIK3CA—stomach cancer	0.000202	0.00038	CbGpPWpGaD
Framycetin—CXCR4—Disease—MYC—stomach cancer	0.0002	0.000377	CbGpPWpGaD
Framycetin—CXCR4—Signaling Pathways—ERBB2—stomach cancer	0.000198	0.000373	CbGpPWpGaD
Framycetin—CXCR4—Disease—MAPK1—stomach cancer	0.000196	0.000369	CbGpPWpGaD
Framycetin—CXCR4—Disease—EGFR—stomach cancer	0.000196	0.000369	CbGpPWpGaD
Framycetin—CXCR4—Signaling Pathways—CXCL8—stomach cancer	0.000188	0.000353	CbGpPWpGaD
Framycetin—CXCR4—Signaling by GPCR—HRAS—stomach cancer	0.000186	0.000351	CbGpPWpGaD
Framycetin—CXCR4—Disease—KRAS—stomach cancer	0.000185	0.000349	CbGpPWpGaD
Framycetin—CXCR4—Signaling Pathways—CDKN1B—stomach cancer	0.000183	0.000345	CbGpPWpGaD
Framycetin—CXCR4—Signaling by GPCR—IL6—stomach cancer	0.000178	0.000336	CbGpPWpGaD
Framycetin—CXCR4—Signaling Pathways—CCND1—stomach cancer	0.000175	0.000329	CbGpPWpGaD
Framycetin—CXCR4—Signaling Pathways—JUN—stomach cancer	0.000174	0.000329	CbGpPWpGaD
Framycetin—CXCR4—Disease—PIK3CA—stomach cancer	0.00017	0.00032	CbGpPWpGaD
Framycetin—CXCR4—Signaling Pathways—MMP9—stomach cancer	0.00017	0.00032	CbGpPWpGaD
Framycetin—CXCR4—Signaling Pathways—CDKN1A—stomach cancer	0.000169	0.000319	CbGpPWpGaD
Framycetin—CXCR4—Signaling Pathways—MAPK8—stomach cancer	0.000165	0.000311	CbGpPWpGaD
Framycetin—CXCR4—Disease—HRAS—stomach cancer	0.000157	0.000296	CbGpPWpGaD
Framycetin—CXCR4—Signaling Pathways—VEGFA—stomach cancer	0.000152	0.000287	CbGpPWpGaD
Framycetin—CXCR4—Signaling Pathways—STAT3—stomach cancer	0.000151	0.000284	CbGpPWpGaD
Framycetin—CXCR4—Disease—IL6—stomach cancer	0.000151	0.000284	CbGpPWpGaD
Framycetin—CXCR4—Signaling Pathways—MAPK3—stomach cancer	0.000144	0.000272	CbGpPWpGaD
Framycetin—CXCR4—Signaling Pathways—MYC—stomach cancer	0.00014	0.000264	CbGpPWpGaD
Framycetin—CXCR4—Signaling Pathways—MAPK1—stomach cancer	0.000137	0.000258	CbGpPWpGaD
Framycetin—CXCR4—Signaling Pathways—EGFR—stomach cancer	0.000137	0.000258	CbGpPWpGaD
Framycetin—CXCR4—Signaling Pathways—KRAS—stomach cancer	0.00013	0.000244	CbGpPWpGaD
Framycetin—CXCR4—Signaling Pathways—PIK3CA—stomach cancer	0.000119	0.000224	CbGpPWpGaD
Framycetin—CXCR4—Signaling Pathways—TP53—stomach cancer	0.000115	0.000217	CbGpPWpGaD
Framycetin—CXCR4—Signaling Pathways—HRAS—stomach cancer	0.00011	0.000207	CbGpPWpGaD
Framycetin—CXCR4—Signaling Pathways—IL6—stomach cancer	0.000105	0.000199	CbGpPWpGaD
